vs
KIRBY CORP（KEX）与百利高（PRGO）财务数据对比。点击上方公司名可切换其他公司
百利高的季度营收约是KIRBY CORP的1.3倍（$1.1B vs $851.8M），KIRBY CORP净利率更高（10.8% vs -127.8%，领先138.6%），KIRBY CORP同比增速更快（6.2% vs -2.5%），KIRBY CORP自由现金流更多（$265.2M vs $148.6M），过去两年KIRBY CORP的营收复合增速更高（2.7% vs 1.3%）
总部位于美国得克萨斯州休斯顿的Kirby Corporation是美国最大的罐驳船运营商，业务覆盖密西西比河水系、海湾沿岸航道、美国三大海岸沿线及阿拉斯加、夏威夷地区，主营通过罐驳船运输石化产品、黑油、精炼石油制品、农化产品，同时拥有并运营8组远洋驳船及拖船运输单元。
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
KEX vs PRGO — 直观对比
营收规模更大
PRGO
是对方的1.3倍
$851.8M
营收增速更快
KEX
高出8.7%
-2.5%
净利率更高
KEX
高出138.6%
-127.8%
自由现金流更多
KEX
多$116.6M
$148.6M
两年增速更快
KEX
近两年复合增速
1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $851.8M | $1.1B |
| 净利润 | $91.8M | $-1.4B |
| 毛利率 | — | 32.6% |
| 营业利润率 | 15.2% | -116.0% |
| 净利率 | 10.8% | -127.8% |
| 营收同比 | 6.2% | -2.5% |
| 净利润同比 | 114.4% | -3093.9% |
| 每股收益（稀释后） | $1.68 | $-10.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KEXPRGO
| Q4 25 | $851.8M | $1.1B | ||
| Q3 25 | $871.2M | $1.0B | ||
| Q2 25 | $855.5M | $1.1B | ||
| Q1 25 | $785.7M | $1.0B | ||
| Q4 24 | $802.3M | $1.1B | ||
| Q3 24 | $831.1M | $1.1B | ||
| Q2 24 | $824.4M | $1.1B | ||
| Q1 24 | $808.0M | $1.1B |
净利润KEXPRGO
| Q4 25 | $91.8M | $-1.4B | ||
| Q3 25 | $92.5M | $7.5M | ||
| Q2 25 | $94.3M | $-8.4M | ||
| Q1 25 | $76.0M | $-6.4M | ||
| Q4 24 | $42.8M | $-44.4M | ||
| Q3 24 | $90.0M | $-21.0M | ||
| Q2 24 | $83.9M | $-108.4M | ||
| Q1 24 | $70.1M | $2.0M |
毛利率KEXPRGO
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 33.1% |
营业利润率KEXPRGO
| Q4 25 | 15.2% | -116.0% | ||
| Q3 25 | 14.8% | 7.0% | ||
| Q2 25 | 15.4% | 4.3% | ||
| Q1 25 | 13.4% | 4.5% | ||
| Q4 24 | 6.3% | 10.0% | ||
| Q3 24 | 15.3% | 7.4% | ||
| Q2 24 | 14.6% | -2.5% | ||
| Q1 24 | 12.6% | -5.1% |
净利率KEXPRGO
| Q4 25 | 10.8% | -127.8% | ||
| Q3 25 | 10.6% | 0.7% | ||
| Q2 25 | 11.0% | -0.8% | ||
| Q1 25 | 9.7% | -0.6% | ||
| Q4 24 | 5.3% | -3.9% | ||
| Q3 24 | 10.8% | -1.9% | ||
| Q2 24 | 10.2% | -10.2% | ||
| Q1 24 | 8.7% | 0.2% |
每股收益（稀释后）KEXPRGO
| Q4 25 | $1.68 | $-10.23 | ||
| Q3 25 | $1.65 | $0.05 | ||
| Q2 25 | $1.67 | $-0.06 | ||
| Q1 25 | $1.33 | $-0.05 | ||
| Q4 24 | $0.74 | $-0.32 | ||
| Q3 24 | $1.55 | $-0.15 | ||
| Q2 24 | $1.43 | $-0.79 | ||
| Q1 24 | $1.19 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.8M | — |
| 总债务越低越好 | $919.3M | — |
| 股东权益账面价值 | $3.4B | $2.9B |
| 总资产 | $6.0B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.27× | — |
8季度趋势，按日历期对齐
现金及短期投资KEXPRGO
| Q4 25 | $78.8M | — | ||
| Q3 25 | $47.0M | $432.1M | ||
| Q2 25 | $68.4M | $454.2M | ||
| Q1 25 | $51.1M | $409.9M | ||
| Q4 24 | $74.4M | $558.8M | ||
| Q3 24 | $67.1M | $1.5B | ||
| Q2 24 | $53.5M | $542.8M | ||
| Q1 24 | $75.2M | $658.5M |
总债务KEXPRGO
| Q4 25 | $919.3M | — | ||
| Q3 25 | $1.0B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $874.9M | — | ||
| Q3 24 | $978.6M | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $1.1B | — |
股东权益KEXPRGO
| Q4 25 | $3.4B | $2.9B | ||
| Q3 25 | $3.4B | $4.4B | ||
| Q2 25 | $3.4B | $4.5B | ||
| Q1 25 | $3.3B | $4.4B | ||
| Q4 24 | $3.4B | $4.3B | ||
| Q3 24 | $3.3B | $4.6B | ||
| Q2 24 | $3.3B | $4.5B | ||
| Q1 24 | $3.2B | $4.7B |
总资产KEXPRGO
| Q4 25 | $6.0B | $8.5B | ||
| Q3 25 | $6.1B | $10.1B | ||
| Q2 25 | $6.1B | $10.1B | ||
| Q1 25 | $6.0B | $9.8B | ||
| Q4 24 | $5.9B | $9.6B | ||
| Q3 24 | $5.9B | $11.2B | ||
| Q2 24 | $5.9B | $10.4B | ||
| Q1 24 | $5.8B | $10.6B |
负债/权益比KEXPRGO
| Q4 25 | 0.27× | — | ||
| Q3 25 | 0.31× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.26× | — | ||
| Q3 24 | 0.30× | — | ||
| Q2 24 | 0.32× | — | ||
| Q1 24 | 0.33× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $312.2M | $175.4M |
| 自由现金流经营现金流 - 资本支出 | $265.2M | $148.6M |
| 自由现金流率自由现金流/营收 | 31.1% | 13.4% |
| 资本支出强度资本支出/营收 | 5.5% | 2.4% |
| 现金转化率经营现金流/净利润 | 3.40× | — |
| 过去12个月自由现金流最近4个季度 | $405.7M | $145.1M |
8季度趋势，按日历期对齐
经营现金流KEXPRGO
| Q4 25 | $312.2M | $175.4M | ||
| Q3 25 | $227.5M | $51.7M | ||
| Q2 25 | $93.9M | $75.9M | ||
| Q1 25 | $36.5M | $-64.5M | ||
| Q4 24 | $247.4M | $312.6M | ||
| Q3 24 | $206.5M | $42.2M | ||
| Q2 24 | $179.3M | $9.5M | ||
| Q1 24 | $123.3M | $-1.4M |
自由现金流KEXPRGO
| Q4 25 | $265.2M | $148.6M | ||
| Q3 25 | $160.3M | $29.8M | ||
| Q2 25 | $22.4M | $56.7M | ||
| Q1 25 | $-42.1M | $-90.0M | ||
| Q4 24 | $150.7M | $274.9M | ||
| Q3 24 | $130.1M | $15.1M | ||
| Q2 24 | $90.8M | $-18.9M | ||
| Q1 24 | $42.2M | $-26.5M |
自由现金流率KEXPRGO
| Q4 25 | 31.1% | 13.4% | ||
| Q3 25 | 18.4% | 2.9% | ||
| Q2 25 | 2.6% | 5.4% | ||
| Q1 25 | -5.4% | -8.6% | ||
| Q4 24 | 18.8% | 24.2% | ||
| Q3 24 | 15.7% | 1.4% | ||
| Q2 24 | 11.0% | -1.8% | ||
| Q1 24 | 5.2% | -2.4% |
资本支出强度KEXPRGO
| Q4 25 | 5.5% | 2.4% | ||
| Q3 25 | 7.7% | 2.1% | ||
| Q2 25 | 8.4% | 1.8% | ||
| Q1 25 | 10.0% | 2.4% | ||
| Q4 24 | 12.0% | 3.3% | ||
| Q3 24 | 9.2% | 2.5% | ||
| Q2 24 | 10.7% | 2.7% | ||
| Q1 24 | 10.0% | 2.3% |
现金转化率KEXPRGO
| Q4 25 | 3.40× | — | ||
| Q3 25 | 2.46× | 6.89× | ||
| Q2 25 | 1.00× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 5.78× | — | ||
| Q3 24 | 2.30× | — | ||
| Q2 24 | 2.14× | — | ||
| Q1 24 | 1.76× | -0.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KEX
| Inland Transportation | $379.2M | 45% |
| Power Generation | $191.1M | 22% |
| Commercial And Industrial | $149.4M | 18% |
| Coastal Transportation | $102.5M | 12% |
| Oil And Gas | $29.6M | 3% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
